Abstract
Aortic stiffness and proteinuria are cardiovascular risk factors that are generally associated with each other. We analysed whether this is true for patients with chronic kidney disease (CKD). We hypothesized that in CKD patients of young age and predominant sole renal disease, aortic stiffness has no predictive value for proteinuria. In a cross-sectional setting, 144 patients with severe-to-mild CKD (estimated glomerular filtration rate (eGFR) 0 to <90 ml min–1 1.73 m–2) were analysed for stiffness, as measured using carotid–femoral pulse wave velocity (C-F PWV), and proteinuria, as determined using protein–creatinine ratio from morning spot urine. In stepwise linear regression analysis, C-F PWV predicted protein–creatinine ratio and vice versa. Younger patients (<50 years) with proteinuria had predominant glomerulonephritis. These were characterized by lower C-F PWV despite similar renal function when compared with younger patients without glomerulonephritis. We conclude that in CKD patients a general relationship exists between aortic stiffness and proteinuria. It is noted that this relation is lost in young CKD patients with predominant sole renal disease. In this study, C-F PWV is not predictive for proteinuria as renal disease is the leading cause of proteinuria.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37 (5): 1236–1241.
Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM . Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99 (18): 2434–2439.
Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106 (14): 1777–1782.
de Jong PE, Brenner BM . From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int 2004; 66 (6): 2109–2118.
de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110 (8): 921–927.
Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T . Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 2004; 27 (7): 471–477.
Smith A, Karalliedde J, De Angelis L, Goldsmith D, Viberti G . Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol 2005; 16 (4): 1069–1075.
Mule G, Cottone S, Vadala A, Volpe V, Mezzatesta G, Mongiovi R et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Int Med 2004; 256 (1): 22–29.
Ishikawa T, Hashimoto J, Morito RH, Hanazawa T, Aikawa T, Hara A et al. Association of microalbuminuria with brachial-ankle pulse wave velocity: the Ohasama study. Am J Hypertens 2008; 21 (4): 413–418.
Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, Bramlage P et al. Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 2007; 96 (5): 247–257.
Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112 (7): 969–975.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro III AF, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Int Med 2009; 150 (9): 604–612.
Frimodt-Moller M, Nielsen AH, Kamper AL, Strandgaard S . Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol Dial Transplant 2008; 23 (2): 594–600.
Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 2006; 69 (2): 350–357.
Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM . Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103 (7): 987–992.
Safar ME, London GM, Plante GE . Arterial stiffness and kidney function. Hypertension 2004; 43 (2): 163–168.
Scuteri A, Tesauro M, Appolloni S, Preziosi F, Brancati AM, Volpe M . Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens 2007; 25 (5): 1035–1040.
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG . Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106 (16): 2085–2090.
Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113 (5): 664–670.
Yokoyama H, Aoki T, Imahori M, Kuramitsu M . Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int 2004; 66 (1): 448–454.
Ohya Y, Iseki K, Iseki C, Miyagi T, Kinjo K, Takishita S . Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis 2006; 47 (5): 790–797.
Lemos MM, Jancikic AD, Sanches FM, Christofalo DM, Ajzen SA, Miname MH et al. Pulse wave velocity--a useful tool for cardiovascular surveillance in pre-dialysis patients. Nephrol Dial Transplant 2007; 22 (12): 3527–3532.
Mogensen CE . Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Int Med 1994; 235 (4): 297–316.
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A . Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32 (4): 219–226.
Volpe M, Cosentino F, Ruilope LM . Is it time to measure microalbuminuria in hypertension? J Hypertens 2003; 21 (7): 1213–1220.
Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am J Epidemiol 2004; 159 (3): 284–293.
Sanders JT, Wyatt RJ . IgA nephropathy and Henoch-Schonlein purpura nephritis. Curr Opin Pediatr 2008; 20 (2): 163–170.
Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001; 59 (5): 1834–1841.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Pan, C., Roos, M., Schmaderer, C. et al. Interrelationship between aortic stiffness and proteinuria in chronic kidney disease. J Hum Hypertens 24, 593–599 (2010). https://doi.org/10.1038/jhh.2009.108
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2009.108
Keywords
This article is cited by
-
Arterial stiffness and decline of renal function in a primary care population
Hypertension Research (2017)